131 related articles for article (PubMed ID: 10469140)
1. Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-kappaB-like transcriptional regulatory motif.
Mahony D; Kalionis B; Antalis TM
Eur J Biochem; 1999 Aug; 263(3):765-72. PubMed ID: 10469140
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: localization of an upstream transcriptional silencer.
Antalis TM; Costelloe E; Muddiman J; Ogbourne S; Donnan K
Blood; 1996 Nov; 88(10):3686-97. PubMed ID: 8916932
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA.
Dear AE; Costa M; Medcalf RL
FEBS Lett; 1997 Feb; 402(2-3):265-72. PubMed ID: 9037208
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression.
Dear AE; Shen Y; Rüegg M; Medcalf RL
Eur J Biochem; 1996 Oct; 241(1):93-100. PubMed ID: 8898893
[TBL] [Abstract][Full Text] [Related]
5. DNase I hypersensitive sites in the 5' flanking region of the human plasminogen activator inhibitor type 2 (PAI-2) gene are associated with basal and tumor necrosis factor-alpha-induced transcription in monocytes.
Mahony D; Stringer BW; Dickinson JL; Antalis TM
Eur J Biochem; 1998 Sep; 256(3):550-9. PubMed ID: 9780231
[TBL] [Abstract][Full Text] [Related]
6. Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter.
Cousin E; Medcalf RL; Bergonzelli GE; Kruithof EK
Nucleic Acids Res; 1991 Jul; 19(14):3881-6. PubMed ID: 1650454
[TBL] [Abstract][Full Text] [Related]
7. Growth state-dependent binding of USF-1 to a proximal promoter E box element in the rat plasminogen activator inhibitor type 1 gene.
White LA; Bruzdzinski C; Kutz SM; Gelehrter TD; Higgins PJ
Exp Cell Res; 2000 Oct; 260(1):127-35. PubMed ID: 11010817
[TBL] [Abstract][Full Text] [Related]
8. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB.
Ohmori Y; Schreiber RD; Hamilton TA
J Biol Chem; 1997 Jun; 272(23):14899-907. PubMed ID: 9169460
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor.
Wang Y; Dang J; Wang H; Allgayer H; Murrell GA; Boyd D
Eur J Biochem; 2000 Jun; 267(11):3248-54. PubMed ID: 10824110
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs.
Tierney MJ; Medcalf RL
J Biol Chem; 2001 Apr; 276(17):13675-84. PubMed ID: 11278713
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor type 2 gene induction by tumor necrosis factor and phorbol ester involves transcriptional and post-transcriptional events. Identification of a functional nonameric AU-rich motif in the 3'-untranslated region.
Maurer F; Medcalf RL
J Biol Chem; 1996 Oct; 271(42):26074-80. PubMed ID: 8824249
[TBL] [Abstract][Full Text] [Related]
12. Genomic structure and functional characterization of the promoter region of human IkappaB kinase-related kinase IKKi/IKKvarepsilon gene.
Wang N; Ahmed S; Haqqi TM
Gene; 2005 Jun; 353(1):118-33. PubMed ID: 15939554
[TBL] [Abstract][Full Text] [Related]
13. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
[TBL] [Abstract][Full Text] [Related]
14. Regulatory sequences and protein-binding sites involved in the expression of the rat plasminogen activator inhibitor-1 gene.
Johnson MR; Bruzdzinski CJ; Winograd SS; Gelehrter TD
J Biol Chem; 1992 Jun; 267(17):12202-10. PubMed ID: 1601887
[TBL] [Abstract][Full Text] [Related]
15. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.
Dawson SJ; Wiman B; Hamsten A; Green F; Humphries S; Henney AM
J Biol Chem; 1993 May; 268(15):10739-45. PubMed ID: 8388372
[TBL] [Abstract][Full Text] [Related]
16. An AU-rich sequence in the 3'-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR.
Maurer F; Tierney M; Medcalf RL
Nucleic Acids Res; 1999 Apr; 27(7):1664-73. PubMed ID: 10075998
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of plasminogen activator inhibitor-1 regulation by oncostatin M and interleukin-1 in human astrocytes.
Kasza A; Kiss DL; Gopalan S; Xu W; Rydel RE; Koj A; Kordula T
J Neurochem; 2002 Nov; 83(3):696-703. PubMed ID: 12390531
[TBL] [Abstract][Full Text] [Related]
18. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
19. Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2.
Antalis TM; Godbolt D; Donnan KD; Stringer BW
Gene; 1993 Dec; 134(2):201-8. PubMed ID: 8262378
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter.
Ogbourne SM; Antalis TM
Nucleic Acids Res; 2001 Oct; 29(19):3919-27. PubMed ID: 11574673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
